Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Healthcare Cannabis Health Care
Nextleaf Solutions Ltd. is a Canada-based company, which is a federally regulated manufacturer and distributor of cannabis vapes and oils under its brand, Glacial Gold. The Company is a cannabis extractor and processor, with a focus on developing intellectual property for the extraction, distillation formulation, and delivery of cannabinoids. It commercializes its intellectual property portfolio through IP licensing, production of cannabidiol (CBD) and tetrahydrocannabinol (THC) oils, through its subsidiary, Nextleaf Labs Ltd. (Labs), and selling products through provincial distribution boards for the adult-use market under the brand Glacial Gold. It sells its branded products to government distributors and authorized retailers in four provinces in Canada. Its patented ingredient processing technology transforms unsold cannabis and hemp biomass into distillate at an industrial scale. Its other subsidiary is Nextleaf Innovations Ltd., which operates as an extraction solutions company.


CSE:OILS - Post by User

Nextleaf Solutions Ltd > CBD for Covid
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(117)
•••
Comment by Adventurouson Jan 23, 2022 2:56pm
168 Views
Post# 34350218

RE:CBD for Covid

RE:CBD for Covid Good find Buyhigh.

Key takeaways:
  • The discovery is only valid for "high-grade CBD preparations". This means a level of sophistication in extraction that only top IP holders like Nextleaf can potentially provide. And we already know that Nextleaf is positioning for partnerships with big pharma.
  • "CBD induces the production of interferons". Interferons are also key agents in combating AIDS and cancers for instance. This opens up a number of long-term perspectives.
I like the idea that my investment in Nextleaf is supporting fondamental medical research.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities